Promoted Content
Promoted Content

Find Clinical Drug Development Pipelines & Deals | PipelineProspector


All Data

Filters Filter refresh
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): SARS-CoV-2 vaccine

            Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed

            Highest Development Status: Undisclosed Product Type: Vaccine

            Partner/Sponsor/Collaborator: Flinders University

            Deal Size: Undisclosed Upfront Cash: Undisclosed

            Deal Type: Partnership May 12, 2020


            Proteona will use its ESCAPE™ technology to profile the immune response of patients receiving the vaccine. The technology will be used by Professor Petrovsky to characterize the clinical response to a new SARS-CoV-2 vaccine which is under investigation.